Literature DB >> 12621273

Cardiac arrhythmias induced by ECT in elderly psychiatric patients: experience with 48-hour Holter monitoring.

Martti J Huuhka1, Lauri Seinelä, Pekka Reinikainen, Esa V J Leinonen.   

Abstract

Serious adverse events associated with electroconvulsive therapy (ECT) are uncommon and consist mostly of cardiovascular complications, mainly arrhythmias. The risk of complications is increased in elderly and physically ill patients. In the current study, a 24-hour pre-ECT and 24-hour post-ECT Holter recording was performed on 26 elderly patients during their first ECT treatment. ECT caused a significant increase in bigeminy/trigeminy and supraventricular tachycardia, but did not increase other arrhythmias. Pre-ECT arrhythmias correlated with post-ECT arrhythmias. All patients in the current study completed the ECT course. Thus, the clinical significance of arrhythmias remains uncertain. The present findings support the usual practice of continuous electrocardiogram monitoring during ECT and recovery.

Entities:  

Mesh:

Year:  2003        PMID: 12621273     DOI: 10.1097/00124509-200303000-00005

Source DB:  PubMed          Journal:  J ECT        ISSN: 1095-0680            Impact factor:   3.635


  3 in total

1.  Acute embolic stroke in a patient with atrial fibrillation after electroconvulsive therapy.

Authors:  Hideaki Suzuki; Takehisa Takano; Miya Tominaga; Kazumasa Suzuki; Yutaka Kagaya
Journal:  J Cardiol Cases       Date:  2010-03-01

2.  Differential heart rate response to magnetic seizure therapy (MST) relative to electroconvulsive therapy: a nonhuman primate model.

Authors:  Stefan B Rowny; Yael M Cycowicz; Shawn M McClintock; Matthew D Truesdale; Bruce Luber; Sarah H Lisanby
Journal:  Neuroimage       Date:  2009-06-02       Impact factor: 6.556

3.  The impact of electroconvulsive therapy on the spatial QRS-T angle and cardiac troponin T concentration in psychiatric patients.

Authors:  Michał Próchnicki; Grzegorz Rudzki; Michał Dzikowski; Andrzej Jaroszyński; Hanna Karakula-Juchnowicz
Journal:  PLoS One       Date:  2019-10-23       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.